Good catch. I read right over that. Agree, perhaps with the caveat of "depending on the disease". For complex, autoimmune conditions, for example, it would appear that 90% of putatively "causal" variants are located in non-coding regions, with 60% found in enhancer regions alone.
Polygenetic Risk Score Calculation
Hello all,
My company has Whole exome sequencing (WES) data for individuals lying around and was wondering if this can be used to generate Polygenic Risk Scores (PRS)? From what I researched online, it seems to be more so used for GWAS and not WES.
Any advice is appreciated!
Roy
2 answers
I wouldn't recommend to this. Most of the component variants in contemporary PRS are non-coding.
• 0 views
•
link
written
by
lassefolkersen •
Yes there is, and as mathematics and logic dictate, it does not substantially differ from calculating PRS for common variants https://www.nature.com/articles/s41467-021-26114-0
Log in to answer this question.
More posts like this
-
Seeking Help for Reanalysis of Raw WES Data
written by lidia.manczak •
-
Emphasizing biological effect of candidate variants used in polygenic risk score
written by K Lee •
-
Recommended Tool for Somatic SV Discovery in Tumor-Only WES Data
written by George •
-
One PRS per phenotype or one for whole sample?
written by katiem •
-
Validatingm Polygenic Risk Scores from PRSice
written by ml1 •
-
Questions about Polygenic Risk Score (PRS) and PRSice-2
written by yiqiangz •
-
News: Course Introduction to GWAS (Genome Wide Association Studies), Nov 25-29, Barcelona (Spain).
written by teresa.rosas •
-
bionano hybrid scaffold
written by lait
-
The effect of sample size and relatedness in target sample in polygenic risk score
written by javadjamshidi •
-
Polygenic risk scoring using PRSice: Error in file(file, "rt") : cannot open the connection
written by dam4l
Quick note: It's Polygenic risk score, not "Polygenetic" risk score. I've changed your question to reflect this.
nature communications october 2021. sounds like your company needs a CGO